Evaluating the translocation properties of a new nuclear targeted penetrating peptide using two fluorescent markers

References

• Brasseur R, Divita G. Happy birthday cell penetrating peptides: already 20 years. Biochim Biophys Acta 2010;1798:2177–81
   PubMed Web of Science ®Google Scholar
• Heitz F, Morris MC, Divita G. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol 2009;157:195–206
   PubMed Web of Science ®Google Scholar
• Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988;55:1189–93
   PubMed Web of Science ®Google Scholar
• Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat Trans-activator protein. Cell 1988;55:1179–88
   PubMed Web of Science ®Google Scholar
• Elliott G, O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 1997;88:223–33
   PubMed Web of Science ®Google Scholar
• Morris MC, Depollier J, Mery J, et al. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 2001;19:1173–6
   PubMed Web of Science ®Google Scholar
• Joliot A, Pernelle C, Deagostini-Bazin H, et al. Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci 1991;88:1864–8
   PubMed Web of Science ®Google Scholar
• Derossi D, Joliot AH, Chassaing G, et al. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 1994;269:10444–50
   PubMed Web of Science ®Google Scholar
• Sabatier JM, Vives E, Mabrouk K, et al. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol 1991;65:961–7
   PubMed Web of Science ®Google Scholar
• Choi JM, Sohn JH, Park TY, et al. Cell permeable NFAT inhibitory peptide Sim-2-VIVIT inhibits T-cell activation and alleviates allergic airway inflammation and hyper-responsiveness. Immunol Lett 2012;43:170–6
   Web of Science ®Google Scholar
• Lim S, Kim W, Kim Y, et al. Identification of a novel cell-penetrating peptide from human phosphatidate phosphatase LPIN3. Mol Cells 2012;34:577–82
   PubMed Web of Science ®Google Scholar
• Niarchos DK, Perez SA, Papamichail M. Characterization of a novel cell penetrating peptide derived from Bag-1 protein. Peptides 2006;27:2661–9
   PubMed Web of Science ®Google Scholar
• Duchardt F, Ruttekolk IR, Verdurmen WPR, et al. A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency. J Biol Chem 2009;284:36099–108
   PubMed Web of Science ®Google Scholar
• Choi JM, Ahn MH, Chae WJ, et al. Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation. Nat Med 2006;12:574–9
   PubMed Web of Science ®Google Scholar
• Zhao J, Gao P, Xiao W, et al. A novel human derived cell-penetrating peptide in drug delivery. Mol Biol Rep 2011;38:2649–56
   PubMed Web of Science ®Google Scholar
• Tyagi M, Rusnati M, Presta M, et al. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 2001;276:3254–61
   PubMed Web of Science ®Google Scholar
• Zorko M, Langel Ü. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev 2005;57:529–45
   PubMed Web of Science ®Google Scholar
• Vives E, Richard J, Rispal C, et al. TAT peptide internalization: seeking the mechanism of entry. Curr Prot Pept Sci 2003;4:125–32
   PubMed Web of Science ®Google Scholar
• Nakase I, Niwa M, Takeuchi T, et al. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Thera 2004;10:1011–22
   PubMed Web of Science ®Google Scholar
• El-Andaloussi S, Johansson HJ, Lundberg P, et al. Induction of splice correction by cell-penetrating peptide nucleic acids. J Gene Med 2006;8:1262–73
   PubMed Web of Science ®Google Scholar
• Simeoni F, Morris MC, Heitz F, et al. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucl Acid Res 2003;31:2717–24
   PubMed Web of Science ®Google Scholar
• Deshayes S, Gerbal-Chaloin S, Morris MC, et al. On the mechanism of non-endosomial peptide-mediated cellular delivery of nucleic acids. Biochim Biophys Acta 2004;1667:141–7
   PubMed Web of Science ®Google Scholar
• Ryu J, Han K, Park J, et al. Enhanced uptake of a heterologous protein with an HIV-1 Tat protein transduction domains (PTD) at both termini. Mol Cell 2003;16:385–91
   Google Scholar
• Kuo JS, Lin CW. Cellular uptake on N-and C-termini conjugated FITC of Rath cell penetrating peptides and its consequences for gene-expression profiling in U-937 human macrophages and HeLa cervical cancer cells. J Drug Target 2013;21:801–8
   PubMed Web of Science ®Google Scholar
• Dietz GPH, Bδhr M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol Cell Neurosci 2004;27:85–131
   PubMed Web of Science ®Google Scholar
• Adachi T, Kodera T, Ohta H, et al. The heparin binding site of human extracellular-superoxide dismutase. Arch Biochem Biophys 1992;297:155–61
   PubMed Web of Science ®Google Scholar
• Ookawara T, Kizaki T, Takayama E, et al. Nuclear translocation of extracellular superoxide dismutase. Biochem Biophys Res Commun 2002;296:54–61
   PubMed Web of Science ®Google Scholar
• Park J, Ryu J, Kim KA, et al. Mutational analysis of a human immunodeficiency virus type 1 Tat protein transduction domain which is required for delivery of an exogenous protein into mammalian cells. J Gen Virol 2002;83:1173–81
   PubMed Web of Science ®Google Scholar
• Boulikas T. Putative nuclear localization signals (NLS) in protein transcription factors. J Cell Biochem 1994;55:32–58
   PubMed Web of Science ®Google Scholar
• Ookawara T, Kizaki T, Takayama E, et al. Nuclear translocation of extracellular superoxide dismutase. Biochem Biophys Res Commun 2002;296:54–61
   PubMed Web of Science ®Google Scholar
• Veach RA, Liu D, Yao S, et al. Receptor/transporter-independent targeting of functional peptides across the plasma membrane. J Biol Chem 2004;279:11425–31
   PubMed Web of Science ®Google Scholar
• Polyakov V, Sharma V, Dahlheimer JL, et al. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. Bioconjugate Chem 2000;11:762–71
   PubMed Web of Science ®Google Scholar
• Hariton-Gazal E, Rosenbluh J, Graessmann A, et al. Direct translocation of histone molecules across cell membranes. J Cell Sci 2003;116:4577–86
   PubMed Web of Science ®Google Scholar
• Richard JP, Melikov K, Brooks H, et al. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem 2005;280:15300–6
   PubMed Web of Science ®Google Scholar
• Vendeville A, Rayne F, Bonhoure A, et al. HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol Biol Cell 2004;15:2347–60
   PubMed Web of Science ®Google Scholar
• Yang XL, Xie J, Niu B, et al. Structure analysis of the protein transduction domain of human Period1 and its mutant analogs. J Mol Graph Model 2005;23:389–94
   PubMed Web of Science ®Google Scholar
• Derossi D, Calvet S, Trembleau A, et al. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 1996;271:18188–93
   PubMed Web of Science ®Google Scholar
• Weller K, Lauber S, Lerch M, et al. Biophysical and biological studies of end-group-modified derivatives of Pep-1. Biochemistry 2005;44:15799–811
   PubMed Web of Science ®Google Scholar